According to the latest report by IMARC Group, titled “Europe DNA Sequencing Products Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027,” The Europe DNA sequencing products market size reached US$ 1.6 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 4.1 Billion by 2027, exhibiting a growth rate (CAGR) of 17.33% during 2022-2027.
Deoxyribonucleic acid (DNA) sequencing products include reagents, equipment, and consumables used to determine the precise order of nucleotide bases and investigate the functions of genes. They assist researchers in analyzing the drug safety and efficacy, which further help in accurate diagnoses or developing personalized treatment plans for patients. Nowadays, DNA sequencing products are extensively used in numerous research studies and applications, including genome editing, forensic sciences, species discovery, hereditary disease detection, and phylogenetic analysis, across Europe.
Request Free Sample Report: https://www.imarcgroup.com/europe-dna-sequencing-products-market/requestsample
Europe DNA Sequencing Products Market Trends and Drivers:
The rising prevalence of congenital and genetic disorders, especially among infants and babies, represents one of the key factors bolstering the market growth across Europe. Apart from this, the introduction of precise DNA sequencing machines that are portable and compact and can be used in remote locations is contributing to the market growth. Furthermore, increasing investments in research and development (RD) activities, along with improving healthcare infrastructure and diagnostic technologies, are impelling the market growth.
Europe DNA Sequencing Products Market 2022-2027 Analysis and Segmentation:
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
The report has segmented the market on the basis on region, product type, application and end user.
Breakup by Product Type:
- Consumables and Reagents
- Equipments
Breakup by Application:
- Biomarkers
- Diagnostics
- Reproductive Health
- Forensics
- Personalized Medicine
- Others
Breakup by End User:
- Academic and Government Research Institutes
- Pharmaceutical and Biotechnology Companies
- Hospitals and Clinics
- Others
Breakup by Country:
- Germany
- France
- United Kingdom
- Italy
- Spain
- Others
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022-2027)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/europe-dna-sequencing-products-market
Note: We are in the process of updating our reports. If you want to receive the latest research data covering the time period from 2023 to 2028, along with industry trends, market size, and competitive analysis, click on the request sample report. The team would be able to deliver the latest version of the report in a quick turnaround time.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
Email: sales@imarcgroup.com
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA
Website: https://www.imarcgroup.com/
Follow us on Twitter: @imarcglobal
Linkedin: https://www.linkedin.com/company/imarc-group
 of 17.33% during 2022-2027.){kind=link}